Back to Search
JEFFREY MOSES, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1447369368IndividualAccepts Medicare
Specialties, Licenses & Credentials
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
131950(NY)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 1974
Research & Publications (20)
Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome.
PMID 18928789·Am J Cardiol·2008
6-review
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
PMID 17896408·Catheter Cardiovasc Interv·2007
3-trial
Efficient high-energy femtosecond pulse compression in quadratic media with flattop beams.
PMID 17767274·Opt Lett·2007
8-other
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials.
PMID 16750680·J Am Coll Cardiol·2006
4-observational
Controllable self-steepening of ultrashort pulses in quadratic nonlinear media.
PMID 17026229·Phys Rev Lett·2006
8-other
Clopidogrel bisulfate: in ST-segment elevation myocardial infarction: a viewpoint by Jeffrey W Moses.
PMID 17192132·Am J Cardiovasc Drugs·2006
4-observational
Soliton compression in quadratic media: high-energy few-cycle pulses with a frequency-doubling crystal.
PMID 16729102·Opt Lett·2006
8-other
Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
PMID 17126649·Am J Cardiol·2006
4-observational
Enhanced long-term antiplatelet therapy after coronary stenting.
PMID 16327052·J Invasive Cardiol·2005
6-review
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.
PMID 15837244·J Am Coll Cardiol·2005
3-trial
Do the beneficial effects of sirolimus-eluting stents extend beyond 1 year?
PMID 16186846·Nat Clin Pract Cardiovasc Med·2005
8-other
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
PMID 14523139·N Engl J Med·2003
3-trial
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial).
PMID 12127611·Am J Cardiol·2002
3-trial
Perspectives of drug-eluting stents: the next revolution.
PMID 14727979·Am J Cardiovasc Drugs·2002
4-observational
Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
PMID 18804877·Int J Cardiol·2010
4-observational
In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study.
PMID 19608137·JACC Cardiovasc Imaging·2009
3-trial
Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
PMID 19539252·JACC Cardiovasc Interv·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 161 FORT WASHINGTON AVE
NEW YORK, NY 10032 - Phone
- (212) 342-3616
Quick Facts
- NPI
- 1447369368
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 52
- Publications
- 20
Are you this provider?
Claim Your Profile